Emerging technologies for monitoring breast cancer response to neoadjuvant chemotherapy: a systematic scoping review [0.03%]
监测新辅助化疗对乳腺癌反应的新兴技术：系统性综述
Georgia C Wright,Luke T Glover,Thomas J E Hubbard
Georgia C Wright
Introduction: Neoadjuvant chemotherapy (NACT) is increasingly used in early breast cancer treatment and responses are highly variable. Accurate monitoring of tumour response is crucial for enabling precise surgical de-esc...
Supplemental imaging modalities for breast cancer screening in women with dense breasts: A systematic review with economic considerations [0.03%]
针对致密乳腺女性乳腺癌筛查的补充影像学手段：具有经济学考量的系统综述研究
Sinéad N Duggan,Mohammad Azharuddin,Rodolfo Hernández et al.
Sinéad N Duggan et al.
Background: Underdiagnosis of breast cancer is a concern for women with dense breasts. This systematic review and meta-analysis evaluates the performance and cost-effectiveness of supplementary imaging modalities plus sta...
Less endocrine therapy in HR+/HER2- breast cancer: a nationwide trend despite unchanged guidelines [0.03%]
激素受体阳性且HER2阴性的乳腺癌接受内分泌治疗的疗程在各国指南建议没有变化的情况下普遍缩短
Eline E F Verreck,Emily L Postma,Tanja Oostergo et al.
Eline E F Verreck et al.
Background: Adjuvant systemic therapy has improved breast cancer outcomes over the past decades. Following the distinction of molecular subtypes and the introduction of gene expression profiling and prognostic tools, chem...
Metastasis-directed thermal ablation in patients with metastatic breast cancer and visceral oligoprogression or oligopersistence: a cohort study [0.03%]
针对内脏寡进展或寡持久转移性乳腺癌患者的转移灶定向热消融治疗：一项队列研究
Nadia Bianco,Carmine Valenza,Monica Milano et al.
Nadia Bianco et al.
Background: Patients with visceral oligoprogressive and oligopersistent metastatic breast cancer (mBC) may benefit from metastasis-directed thermal ablation (TA) to all sites of metastasis, while maintaining the same syst...
Outcomes for ER-positive CHEK2 c.1100delC breast cancer patients compared with breast cancer patients without the variant [0.03%]
携带CHEK2 c.1100delC基因变异的ER阳性乳腺癌患者与无该变异的乳腺癌患者的预后比较
Maartje A C Schreurs,Muriel A Adank,Bernadette A M Heemskerk-Gerritsen et al.
Maartje A C Schreurs et al.
Purpose: Germline CHEK2 c.1100delC-associated breast cancer (BC) patients have been reported with worse prognosis than patients without the variant. However, results are based on older cohorts and treatment regimens. As p...
Real-world outcomes with palbociclib, ribociclib, and abemaciclib plus endocrine therapy in HR+/HER2- advanced breast cancer: A multicenter retrospective study [0.03%]
palbociclib、ribociclib和abemaciclib联合内分泌治疗HR+/HER2-晚期乳腺癌的现实世界结果：一项多中心回顾性研究
Renata Duchnowska,Katarzyna Soter,Katarzyna Pogoda et al.
Renata Duchnowska et al.
Background: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) combined with endocrine therapy (ET) are the standard first- and second-line treatments for hormone receptor-positive (HR+), HER2-negative (HER2-) advanced brea...
Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03 [0.03%]
纳武单抗联合伊匹木单抗对比卡培他滨用于新辅助化疗后存在残留病灶的三阴性乳腺癌患者的术后治疗：一项多中心、随机、开放标签II期临床试验（BREASTIMMUNE-03）
Olivier Trédan,Delphine Loirat,Sylvie Chabaud et al.
Olivier Trédan et al.
Background: Triple negative breast cancer (TNBC) patients with residual disease after neoadjuvant chemotherapy (NAC) face high risk of recurrence. BREASTIMMUNE-03 trial evaluates the efficacy of nivolumab and ipilimumab c...
Critical appraisal of a machine learning model for predicting internal mammary lymph node metastasis in breast cancer [0.03%]
评估用于预测乳腺癌胸肌间淋巴结转移的机器学习模型ritical appraisal of a machine learning model for predicting internal mammary lymph node metastasis in breast cancer
Kun Fang,Suxiao Jiang,Ping Zhang
Kun Fang
Advancing the legal rights of people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 10) [0.03%]
推进晚期乳腺癌患者的法律权益：一项全球专家审查和行动呼吁（目标10）
Sarah McHutchison,Tarishi Desai,Hayley Jones et al.
Sarah McHutchison et al.
A diagnosis of advanced breast cancer (ABC) can be life-altering, presenting challenges that extend far beyond the clinical domain. Among these challenges is the ability to continue or return to work, a decision often influenced by financia...